Oracle Announces Creation of Health Sciences Global Business Unit
New Organization to Help Pharmaceutical, Biotechnology, Medical Device and Healthcare Companies Accelerate Insights for Better Health
June 23, 2008
Responding to continued growth in clinical trials as well as the increasing linkages across life sciences, diagnostics and healthcare, Oracle today announced the formation of a new Global Business Unit focused on software applications for the health sciences industry. Neil de Crescenzo has been named Senior Vice President and General Manager for the business unit.
The Oracle Health Sciences Global Business Unit will build on Oracle's proven track record in the sector. Today, 20 of the 20 top pharmas and 14 of the 15 top U.S. hospitals run Oracle.
The Oracle Health Sciences Global Business Unit will help health sciences organizations discover, develop and successfully market innovative products and services to prevent and cure disease, enhance quality of life and meet their shareholder and stakeholder expectations.
Oracle today offers the sector's most comprehensive suite of software applications for clinical development. These products can be deployed individually or together and include Oracle Clinical, Oracle Remote Data Capture, Oracle Thesaurus Management System, Oracle Adverse Event Reporting System, Oracle Life Sciences Data Hub and Oracle's Siebel Clinical Trial Management System.
Oracle's application platform for health sciences helps companies bring together all the critical aspects of the clinical development, safety and pharmacovigilance processes into a single, open platform built on state-of-the-art technology.
Oracle's clinical applications provide a streamlined system for managing large volumes of patient data collected during clinical trials. They offer features for modeling any kind of clinical study, automatically storing components for reuse in a flexible global library.
The company also offers Oracle Healthcare Transaction Base, which helps healthcare companies simultaneously improve patient care and control costs by providing a foundation for interoperability and integration of existing and new systems.
"Accenture believes the industry needs to move to a more integrated set of clinical capabilities to realize the strategic value of the data available to support research and development," said Arjun Bedi, Global Lead of Accenture's Health & Life Sciences R&D practice. "We welcome efforts like Oracle's to bring together and enhance the necessary components to enable such a capability. With our range of services and the right software components, we can help our clients realize more business value from their R&D investments."
"There is a dramatic transformation taking place today in life sciences, diagnostics and healthcare in order to accelerate insights for better health. The creation of the Oracle Health Sciences Global Business Unit signals Oracle's commitment to this important sector and our focus on delivering value to health sciences organizations by offering them a comprehensive set of capabilities and superior ownership experience," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit.